Literature DB >> 23255161

ITCH regulates degradation of mutant glucocerebrosidase: implications to Gaucher disease.

Gali Maor1, Mirella Filocamo, Mia Horowitz.   

Abstract

Inability to properly degrade unfolded or misfolded proteins in the endoplasmic reticulum (ER) leads to ER stress and unfolded protein response. This is particularly important in cases of diseases in which the mutant proteins undergo ER-associated degradation (ERAD), as in Gaucher disease (GD). GD is a genetic, autosomal recessive disease that results from mutations in the GBA1 gene, encoding the lysosomal enzyme acid β-glucocerebrosidase (GCase). We have shown that mutant GCase variants undergo ERAD, the degree of which is a major determinant of disease severity. Most ERAD substrates undergo polyubiquitination and proteasomal degradation. Therefore, one expects that mutant GCase variants are substrates for several E3 ubiquitin ligases in different cells. We tested the possibility that ITCH, a known E3 ubiquitin ligase, with a pivotal role in proliferation and differentiation of the skin, recognizes mutant GCase variants and mediates their polyubiquitination and degradation. Our results strongly suggest that ITCH interacts with mutant GCase variants and mediates their lysine 48 polyubiquitination and degradation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23255161     DOI: 10.1093/hmg/dds535

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  9 in total

1.  Enzyme enhancers for the treatment of Fabry and Pompe disease.

Authors:  Jan Lukas; Anne-Marie Pockrandt; Susanne Seemann; Muhammad Sharif; Franziska Runge; Susann Pohlers; Chaonan Zheng; Anne Gläser; Matthias Beller; Arndt Rolfs; Anne-Katrin Giese
Journal:  Mol Ther       Date:  2014-11-20       Impact factor: 11.454

2.  Mutant glucocerebrosidase in Gaucher disease recruits Hsp27 to the Hsp90 chaperone complex for proteasomal degradation.

Authors:  Chunzhang Yang; Herui Wang; Dongwang Zhu; Christopher S Hong; Pauline Dmitriev; Chao Zhang; Yan Li; Barbara Ikejiri; Roscoe O Brady; Zhengping Zhuang
Journal:  Proc Natl Acad Sci U S A       Date:  2015-01-12       Impact factor: 11.205

Review 3.  Exploring genetic modifiers of Gaucher disease: The next horizon.

Authors:  Brad A Davidson; Shahzeb Hassan; Eric Joshua Garcia; Nahid Tayebi; Ellen Sidransky
Journal:  Hum Mutat       Date:  2018-09-11       Impact factor: 4.878

Review 4.  Gaucher disease: the metabolic defect, pathophysiology, phenotypes and natural history.

Authors:  Hagit N Baris; Ian J Cohen; Pramod K Mistry
Journal:  Pediatr Endocrinol Rev       Date:  2014-09

5.  TRIP12 ubiquitination of glucocerebrosidase contributes to neurodegeneration in Parkinson's disease.

Authors:  Bo Am Seo; Donghoon Kim; Heehong Hwang; Min Seong Kim; Shi-Xun Ma; Seung-Hwan Kwon; Sin Ho Kweon; Hu Wang; Je Min Yoo; Seulah Choi; Sang Ho Kwon; Sung-Ung Kang; Tae-In Kam; Kwangsoo Kim; Senthilkumar S Karuppagounder; Bong Gu Kang; Saebom Lee; Hyejin Park; Sangjune Kim; Wei Yan; Yong-Shi Li; Sheng-Han Kuo; Javier Redding-Ochoa; Olga Pletnikova; Juan C Troncoso; Gabsang Lee; Xiaobo Mao; Valina L Dawson; Ted M Dawson; Han Seok Ko
Journal:  Neuron       Date:  2021-10-12       Impact factor: 17.173

Review 6.  Glucocerebrosidase is shaking up the synucleinopathies.

Authors:  Marina Siebert; Ellen Sidransky; Wendy Westbroek
Journal:  Brain       Date:  2014-02-14       Impact factor: 13.501

7.  Lysosomal Enzyme Glucocerebrosidase Protects against Aβ1-42 Oligomer-Induced Neurotoxicity.

Authors:  Seulah Choi; Donghoon Kim; Tae-In Kam; Seungpil Yun; Sangjune Kim; Hyejin Park; Heehong Hwang; Olga Pletnikova; Juan C Troncoso; Valina L Dawson; Ted M Dawson; Han Seok Ko
Journal:  PLoS One       Date:  2015-12-02       Impact factor: 3.240

Review 8.  Neuronopathic Gaucher disease: Beyond lysosomal dysfunction.

Authors:  Nohela B Arévalo; Cristian M Lamaizon; Viviana A Cavieres; Patricia V Burgos; Alejandra R Álvarez; María J Yañez; Silvana Zanlungo
Journal:  Front Mol Neurosci       Date:  2022-08-03       Impact factor: 6.261

9.  Parkin-mediated ubiquitination of mutant glucocerebrosidase leads to competition with its substrates PARIS and ARTS.

Authors:  Inna Bendikov-Bar; Debora Rapaport; Sarit Larisch; Mia Horowitz
Journal:  Orphanet J Rare Dis       Date:  2014-06-16       Impact factor: 4.123

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.